Understanding the Surge in AFRM Stock Today

This afternoon we watched Affirm rise 3.6% to a price of $29.86 per share. The Mid-Cap Diversified Financial company is now trading -16.41% below its average target price of $35.72. Analysts have set target prices ranging from $20.0 to $65.0 per share for Affirm, and have given the stock an average rating of hold.

Affirm has an elevated short interest of 12.9%. The stock's short ratio, or the number of days needed for all shorts to cover their positions, is 4.03. Only 4.83% of the company's shares are owned by insiders, indicating that management does not have a deep alignment of interest with its shareholders. 83.0% of Affirm shares are held by institutional investors, which indicates a high level of confidence in the stock.

Institutions Invested in Affirm

Date Reported Holder Percentage Shares Value
2024-03-31 Morgan Stanley 12% 30,569,187 $912,795,942
2024-03-31 Vanguard Group Inc 8% 20,823,803 $621,798,770
2024-03-31 Capital Research Global Investors 7% 19,419,985 $579,880,763
2024-03-31 Capital World Investors 7% 19,079,071 $569,701,071
2024-03-31 Baillie Gifford and Company 7% 18,732,407 $559,349,684
2024-03-31 Blackrock Inc. 4% 9,965,847 $297,580,197
2024-03-31 Shaw D.E. & Co., Inc. 3% 9,071,991 $270,889,656
2024-03-31 Geode Capital Management, LLC 1% 3,821,486 $114,109,574
2024-03-31 State Street Corporation 1% 3,760,116 $112,277,066
2024-03-31 Two Sigma Advisers, LP 1% 3,556,500 $106,197,092

For these reasons, we consider that the Affirm is the subject of mixed market sentiment.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS